| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Technetium (99m-Tc) macrosalb (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) mertiatide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) sodium pertechnetate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) microaggregated albumin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) disofenin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) oxidronate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) sestamibi (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) medronate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Static radionuclide imaging of spleen using technetium (99m-Tc) (procedure) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Static radionuclide imaging of liver and spleen using technetium (99m-Tc) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Static radionuclide imaging of liver and spleen using technetium (99m-Tc) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
2 |
| Dynamic radionuclide imaging of liver using technetium (99m-Tc) (procedure) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Radionuclide imaging of liver using technetium (99m-Tc) with hepatic perfusion index (procedure) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Dynamic radionuclide imaging of spleen using technetium (99m-Tc) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Dynamic radionuclide imaging of liver and spleen using technetium (99m-Tc) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Dynamic radionuclide imaging of liver and spleen using technetium (99m-Tc) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
2 |
| Dual isotope single photon emission computed tomography of parathyroid using technetium-99m and thallium-201 (procedure) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
2 |
| Dual isotope single photon emission computed tomography with computed tomography of parathyroid using technetium-99m and thallium-201 (procedure) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
2 |
| Technetium (99m-Tc) bicisate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Radionuclide imaging of parathyroid using technetium (99m-Tc) and thallium-201 (procedure) |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
2 |
| Technetium (99m-Tc) tilmanocept |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) human serum albumin |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) pentetic acid (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) sucralfate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) pentavalent succimer (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) technegas |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) labelled granulocytes |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) human immunoglobulin G |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) rhenium sulfide colloid (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| DTPA aerosol ventilation study |
Using substance (attribute) |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Product containing only technetium-99m (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Product containing only technetium-99m in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Technetium-99m-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
1 |
| Technetium (99m-Tc) ethylenedicysteine (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) alendronate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) nanocolloid (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) ethyl cysteinate dimer |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) labeled prostate specific membrane antigen |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) labeled somatostatin analog |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) labeled besilesomab |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) labeled monoclonal antibody (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) labeled 3,3-diphosphono-1,2-propanodicarboxylic acid (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Technetium-99m (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]